SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 ...

The key player in SARS-CoV-2's infection process is the receptor binding domain (RBD) of the spike protein. The RBD determines how well the virus binds to ACE2, the human cellular receptor ...

Two weeks ago, a blogger wrote about a Yale School of Medicine study that he alleged proved that millions of long COVID sufferers might, in fact, have been injured by the vaccine. The story blew up on ...

"The 'key' is the viral spike protein and the 'lock' is the cell's ACE2 receptor. The 'teeth' on the key are the spike amino ...

Swipe to advance through slides First, It Binds to a Lung Cell When a virus spike protein latches onto an ACE2 receptor, a protease enzyme slices off the spike's head. (ACE2 normally helps ...

The spike protein of the new coronavirus infected human cells that had high levels of the ACE2 receptor in test tubes, as well as in small models of human airways and intestines. The researchers ...

Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors. Blocking this interaction with inhibitors could ...

Get Instant Summarized Text (Gist) CeSPIACE is a peptide inhibitor designed to block the interaction between the SARS-CoV-2 spike protein and ACE2 receptors, preventing infection. It remains ...